Screening for Obstructive Respiratory Disorders in the General Population During the "Mai Poumon 2026" Prevention Campaign: Prevalence and Impact on the Care Pathway

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier de la côte Basque

About this trial

Undiagnosed COPD represents a significant issue in terms of morbidity and mortality, as nearly 50% of smokers with chronic respiratory symptoms also experience impaired quality of life and acute events similar to COPD exacerbations. We aim to study the prevalence of airflow obstruction (AO) and PRISm (preserved ratio impaired spirometry) in the general population.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Participating to the prevention campain "Mai Poumons 2026" on 09 Mai 2026

Disqualifiers

Contre-indication to perform a spirometry : hemoptysy, pneumothorax, myocardal infarction <1month, thoracic anevrism, recent ophtalmologic, abdominal or thoracic surgery

Unable to perform a spirometry (understanding, coordination)

Patient under legal protection

Patient pregnant or breasting

Trial design

Treatments tested in this trial

  • Spirometry

Treatment groups

No treatment groups listed

Locations

This trial has no locations